https://www.selleckchem.com/pr....oducts/acss2-inhibit
512 ± 164 × 109/L, p less then 0.001).Conclusion Thrombocytosis in acute phase KD was associated with poor clinical outcomes such as IVIG non-responsiveness, CAD, and prolonged admission and fever durations. What is Known • Thrombocytopenia in the acute phase of KD is related to non-responsiveness to IVIG and the risk of coronary artery dilatation. • The exact significance of thrombocytosis in the acute phase of KD as a benign phenomenon or a signal of poor outcome of KD is unclear. What is New • Thrombocytosis in acute phase KD
Like
Comment
Share
